GE HealthCare Technologies (GEHC) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.34
- Estimate
- $1.20
- Surprise
- +11.3%
- Revenue (period 2026-09-30)
- $5.51B
- Score at report (before → after)
- 5.9 → 5.9/10
Revenue source: xbrl.
How the report landed
GE HealthCare Technologies (GEHC) beat the $1.20 estimate with adjusted EPS of $1.34 — a large 11.3% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.9/10) to Hold at 5.9/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates GEHC Hold at 5.8/10.
3 of the last 4 quarters beat the estimate; this quarter's +11.3% surprise compares with a +4.4% four-quarter average. Next scheduled report: 2027-02-03.
What supports the rating
- Strong earnings beat streak (3/4)
- Strong growth profile
What argues against it
- Analyst target reached - limited upside remaining
- Negative momentum
- Target reached (-5.3% upside)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $83.49
- Stop
- $78.35
At 17.3× trailing and 14.9× forward earnings, consensus estimates imply little change in earnings power.
Model outputs from TrendMatrix’s engine as of 2026-11-18 — shown for context, not personalized investment advice.
GEHC at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $37.00B
- P/E (fwd)
- 14.9
- P/E (ttm)
- 17.3
- 52-week range
- $58.75–$89.77
- Off 52-week high
- 7.0%
- RSI (14)
- 67
- Volume vs avg
- 0.38×
- Score today
- 5.8/10